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Letters to the Editor
SURVEILLANCE AGAINST NEOPLASTIC CELLS-IS IT
MEDIATED BY MACROPHAGES?
SIR,-Dr Robert Schwartz has argued in
a stimulating and convincing way in an
editorial of the New England Medical Journal
of Medicine (Schwartz, 1975) that specific
immunity (defined as reactions which, like
the rejection of foreign grafts, are directed
against specific antigens and which require
the lymphoid machinery of the body) is
unlikely to determine in most instances the
rate at which clinical cancer occurs, either
spontaneously (Sanford et al., 1973) or in
response to a deliberate carcinogen (Stutman,
1974). I fully concur with the view that
the concept of immune surveillance of
cancer, as stated by MacFarlane Burnet
though not in the broader sense in which
it was used by Paul Ehrlich, has not stood
up to experimental scrutiny. But this
failure does not imply that there is no
surveillance mechanism in the body which
eliminates neoplastic cells as they are
formed by a process that recognizes some
general surface characteristic of tumour
cells. The need for such a mechanism
derives from observations which indicate
that neoplastic cells arise much more fre-
quently than do clinically detectable cancers.
Thus, in unselected autopsies and surgical
biopsies of non-cancer patients, malignant
lesions are very much more common than
the observed rate of malignancies in the
population; in the case of neuroblastomata
ofyoung children, the difference in frequency
may be as much as 50 times. Experiment-
ally, it was found that cells exposed in vitro
to carcinogens undergo a transformation to
the neoplastic state at an unexpectedly
high frequency. After culture needed to
produce sufficient cells, such transformants
induce cancer when inoculated into suitable
animals. For example, one in 500 of the
cells in a culture of fibroblasts is transformed
by 50 rad of x-rays (Borek and Hall, 1974).
If there were no mechanism by which
newly arisen neoplastic cells are eliminated in
vivo, the carcinogenicity of x-rays would
be immensely greater than that actually
observed.
The hypothesis that recognition and
destruction of transformed cells as they
arise is effected by macrophages is based
on experiments in which macrophages were
shown to become cytotoxic to a range of
sarcomata and lymphoma cells following
exposure in vitro and in vivo to endotoxin
and dsRNA at very low concentrations
(Alexander and Evans, 1971). Lympho-
cytes are not involved in this reaction and
macrophages from T-cell-deprived mice
that are unable to mount specific immune
reactions can be rendered cytotoxic by such
treatments. Hibbs (1973) showed that the
cytotoxic activity of endotoxin-treated
macrophages was selective for transformed
cells and left normal cells intact. Such
tumoricidal macrophages were referred to
by us as being " activated " (Alexander &
Evans, 1971) but this was an unfortunate
terminology since it had previously been
applied also to macrophages treated by
procedures that stimulated metabolism with-
out inducing cytotoxic potential.
The tumoricidal macrophage fulfils the
requirement for a surveillance mechanism
that can operate selectively against neo-
plastic cells in the absence of specific im-
munity. The elucidation of the mechanism
by which such macrophages recognize neo-
plastically transformed cells is a major
research challenge. Teleologically, it is
tempting to link such a reaction to the
defence mechanisms against infection in
lower organisms, which is mainly by phago-
cytic cells that distinguish self from invading
cells and viruses. Indeed, even in mammals
the first line of defence against infection
is frequently phagocytes, with specific
immunity acting as the backup mechanism.
As in infection (Mackaness, 1969), so
also in cancer (Evans and Alexander, 1970),
macrophages can affect immunologically
specific cytotoxic reactions by acting inLETTERS TO THE EDITOR 345
cooperation with lymphocytes that, have
been triggered by specific antigen. After
recognizing tumour-specific antigens lympho-
cytes arni in vitro and in vivo macrophages
that then acquire the capacity to kill the
specific target cell. These specifically cyto-
toxic macrophages, as opposed to those
wvhich are generally tumoricidal, are only
produced in animals with functioning T
cells (Grant, Evans and Alexander, 1973).
The complicating factor is that such specific
macrophages can be rendered generally
tumoricidal by contact with a specific
antigen (Evans and Alexander, 1972) and
by lymphokines released when antigens
meet immune lymphoid eells (Evans, Cox
and Alexander, 1973; Piessens et al., 1975).
Consequently, as was shown by Hibbs,
Lambert and Remington (1972), animals
w,vith persistent infection are frequently more
resistant, to cancer and their macrophages
are tumoricidal. It must therefore be
emphasized that nonspecifically tumoricidal
macrophages can be obtained both by
reactions that require a normally functioning
immune mechanism and by procedures that
do not. The latter may be those that are
relevant for surveillance against incipient
neoplastic cells which can occur in the
absence of cells needed for specific immunity.
Specific immunity directed against tumour
antigens may, however, play an important
role in the biological behaviour of a tumour
once it has arisen. Thus, in experimental
animals (Eecles and Alexander, 1974) pro-
cedures which deplete T cells but leave
monocyte-macrophage activity intact pro-
mote metastatic spread in rats and impair
the therapeutic effect of anti-cancer chemo-
therapy. I hypothesize that in cancer, as
in infection, small numbers of cells can be
eliminated by processes that? have a broad
degree of discrimination betw%een normal and
abnormal but that the control of large
numbers of cells in clinically evident disease
requires the more potent effector processes
of specific immunity.
PETER ALEXANDER
Division of Tumour Immunology,
Chester Beatty Research Institute,
Sutton, Surrey, England.
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